[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Bioaffinity Technologies Inc (BIAF)

Bioaffinity Technologies Inc (BIAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,701
  • Shares Outstanding, K 592
  • Annual Sales, $ 6,160 K
  • Annual Income, $ -14,910 K
  • EBIT $ -12 M
  • EBITDA $ -11 M
  • 60-Month Beta -1.04
  • Price/Sales 0.47
  • Price/Cash Flow N/A
  • Price/Book 0.58

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.56 +45.79%
on 08/31/26
9.30 -28.52%
on 08/03/26
-2.76 (-29.36%)
since 07/31/26
3-Month
4.56 +45.79%
on 08/31/26
32.63 -79.62%
on 06/02/26
-19.60 (-74.67%)
since 06/01/26
52-Week
4.56 +45.79%
on 08/31/26
202.50 -96.72%
on 09/15/25
-102.30 (-93.90%)
since 08/29/25

Most Recent Stories

More News
bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors

More than 680,000 Americans living with a history of lung cancer represent a significant population requiring ongoing surveillance Noninvasive CyPath® Lung has the potential...

BIAF : 6.71 (+47.15%)
BIAFW : 0.1106 (+47.27%)
bioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026

bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) , a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced...

BIAF : 6.71 (+47.15%)
BIAFW : 0.1106 (+47.27%)
bioAffinity Technologies and AvMEDICAL Announce Nationwide Federal Healthcare Distribution Agreement for CyPath® Lung

New partner’s national sales force will market CyPath Lung to federal healthcare agencies, including VA medical centers nationwide Agreement significantly...

BIAF : 6.71 (+47.15%)
BIAFW : 0.1106 (+47.27%)
WallachBeth Capital Announces Closing of bioAffinity Technologies $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules

JERSEY CITY, N.J. , Aug. 14, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced that bioAffinity Technologies, Inc....

BIAF : 6.71 (+47.15%)
BIAFW : 0.1106 (+47.27%)
bioAffinity Technologies Announces Closing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced that it has closed its previously...

BIAF : 6.71 (+47.15%)
BIAFW : 0.1106 (+47.27%)
WallachBeth Capital Announces bioAffinity Technologies Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules

JERSEY CITY, N.J.,  , Aug. 13, 2026 /PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced that bioAffinity Technologies,...

BIAF : 6.71 (+47.15%)
BIAFW : 0.1106 (+47.27%)
bioAffinity Technologies Announces Pricing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced that it has entered into a securities...

BIAF : 6.71 (+47.15%)
BIAFW : 0.1106 (+47.27%)
bioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath® Lung

CyPath Lung test volume increased 216% year over year in Q2 2026 Company drives physician adoption of CyPath Lung and advances longitudinal clinical...

BIAF : 6.71 (+47.15%)
BIAFW : 0.1106 (+47.27%)
bioAffinity Technologies Publishes New Clinical Framework Addressing Growing Market for Pulmonary Nodule Risk Stratification and Early Lung Cancer Detection Using CyPath® Lung

Comprehensive clinical review outlines specialty-specific approaches for integrating the test’s lung microenvironment analysis into diagnostic pathway ...

BIAF : 6.71 (+47.15%)
BIAFW : 0.1106 (+47.27%)
bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity’s Diagnostics for Asthma and COPD

Collaboration increases laboratory throughput and reduces costs for personalized testing for asthma and COPD, which affect more than 40 million Americans and 650 million people worldwide ...

BIAF : 6.71 (+47.15%)
BIAFW : 0.1106 (+47.27%)

Business Summary

bioAffinity Technologies Inc. is a cancer diagnostics company which develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung and is researching targeted therapies to treat cancer. bioAffinity Technologies Inc. is based in SAN ANTONIO.

See More

Key Turning Points

3rd Resistance Point 5.26
2nd Resistance Point 5.12
1st Resistance Point 4.84
Last Price 6.71
1st Support Level 4.42
2nd Support Level 4.28
3rd Support Level 4.00

See More

52-Week High 202.50
Fibonacci 61.8% 126.89
Fibonacci 50% 103.53
Fibonacci 38.2% 80.17
Last Price 6.71
52-Week Low 4.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.